Literature DB >> 26609009

Can ovarian suppression with gonadotropin-releasing hormone analogs (GnRHa) preserve fertility in cancer patients?

K Rodriguez-Wallberg1, V Turan2, P Munster3, K Oktay4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26609009      PMCID： PMC6267935          DOI： 10.1093/annonc/mdv554

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  5 in total

1.  Failure of Ovarian Suppression With Gonadotropin-Releasing Hormone Analogs to Preserve Fertility: An Assessment Based on the Quality of Evidence.

Authors:  Kutluk Oktay; Volkan Turan
Journal:  JAMA Oncol       Date:  2016-01       Impact factor: 31.777

2.  Gonadotropin-releasing hormone agonist for the prevention of chemotherapy-induced ovarian failure in patients with lymphoma: 1-year follow-up of a prospective randomized trial.

Authors:  Isabelle Demeestere; Pauline Brice; Fedro A Peccatori; Alain Kentos; Isabelle Gaillard; Pierre Zachee; Rene-Olivier Casasnovas; Eric Van Den Neste; Julie Dechene; Vivianne De Maertelaer; Dominique Bron; Yvon Englert
Journal:  J Clin Oncol       Date:  2012-11-05       Impact factor: 44.544

Review 3.  Protecting Ovaries During Chemotherapy Through Gonad Suppression: A Systematic Review and Meta-analysis.

Authors:  Eman Elgindy; Hoda Sibai; Amany Abdelghani; Magdy Mostafa
Journal:  Obstet Gynecol       Date:  2015-07       Impact factor: 7.661

4.  Adjuvant exemestane with ovarian suppression in premenopausal breast cancer.

Authors:  Olivia Pagani; Meredith M Regan; Barbara A Walley; Gini F Fleming; Marco Colleoni; István Láng; Henry L Gomez; Carlo Tondini; Harold J Burstein; Edith A Perez; Eva Ciruelos; Vered Stearns; Hervé R Bonnefoi; Silvana Martino; Charles E Geyer; Graziella Pinotti; Fabio Puglisi; Diana Crivellari; Thomas Ruhstaller; Eric P Winer; Manuela Rabaglio-Poretti; Rudolf Maibach; Barbara Ruepp; Anita Giobbie-Hurder; Karen N Price; Jürg Bernhard; Weixiu Luo; Karin Ribi; Giuseppe Viale; Alan S Coates; Richard D Gelber; Aron Goldhirsch; Prudence A Francis
Journal:  N Engl J Med       Date:  2014-06-01       Impact factor: 91.245

Review 5.  Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies.

Authors:  M Lambertini; M Ceppi; F Poggio; F A Peccatori; H A Azim; D Ugolini; P Pronzato; S Loibl; H C F Moore; A H Partridge; P Bruzzi; L Del Mastro
Journal:  Ann Oncol       Date:  2015-09-07       Impact factor: 32.976
  5 in total
  4 in total

Review 1.  Fertility preservation in ovarian tumours.

Authors:  Federica Tomao; Anna Di Pinto; Carolina Maria Sassu; Erlisa Bardhi; Violante Di Donato; Ludovico Muzii; Maria Cristina Petrella; Fedro Alessandro Peccatori; Pierluigi Benedetti Panici
Journal:  Ecancermedicalscience       Date:  2018-12-06

Review 2.  Fertility Preservation Using GnRH Agonists: Rationale, Possible Mechanisms, and Explanation of Controversy.

Authors:  Zeev Blumenfeld
Journal:  Clin Med Insights Reprod Health       Date:  2019-08-21

Review 3.  Burning Questions in the Oncofertility Counseling of Young Breast Cancer Patients.

Authors:  Luca Arecco; Marta Perachino; Alessandra Damassi; Maria Maddalena Latocca; Davide Soldato; Giacomo Vallome; Francesca Parisi; Maria Grazia Razeti; Cinzia Solinas; Marco Tagliamento; Stefano Spinaci; Claudia Massarotti; Matteo Lambertini
Journal:  Breast Cancer (Auckl)       Date:  2020-09-04

4.  Development and internal validation of a Nomogram for preoperative prediction of surgical treatment effect on cesarean section diverticulum.

Authors:  Yizhi Wang; Qinyi Zhu; Feikai Lin; Li Xie; Jiarui Li; Xipeng Wang
Journal:  BMC Womens Health       Date:  2019-11-11       Impact factor: 2.809
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.